Literature DB >> 22265153

Clinical outcomes of repeat autologous cultivated limbal epithelial transplantation for ocular surface burns.

Sayan Basu1, Hasnat Ali, Virender S Sangwan.   

Abstract

PURPOSE: To report the clinical outcomes of repeat autologous cultivated limbal epithelial transplantation in patients with recurrence of limbal stem cell deficiency after a failed primary procedure.
DESIGN: Retrospective case series.
METHODS: This study included 50 patients, above 8 years of age, with clinically diagnosed unilateral limbal stem cell deficiency following ocular surface burns, treated between 2001 and 2010. Following failure of primary surgery all patients underwent a repeat limbal biopsy from the unaffected eye. The limbal cells were expanded ex vivo on a human amniotic membrane substrate for 10 to 14 days using a completely xeno-free explant culture technique. The resulting cultured epithelial monolayer and amniotic membrane were transplanted onto the patient's affected eye. All patients underwent a comprehensive ophthalmic examination of both eyes at every follow-up visit. Postoperative corneal surface stability, change in visual acuity, and complications were objectively analyzed.
RESULTS: At a mean follow-up of 2.3±1.4 (median: 1.96, range: 1 to 7.5) years, 33 of the 50 recipient eyes (66%) maintained a completely epithelialized, avascular, and clinically stable corneal surface. A 2-line improvement in visual acuity was seen in 38 of the 50 recipient eyes (76%). None of the donor eyes developed any clinical features of ocular surface disease, conjunctival overgrowth of the donor site, or decrease in vision throughout the follow-up period.
CONCLUSIONS: Repeat autologous cultivated limbal epithelial transplantation successfully restores corneal epithelial stability and improves vision in eyes with recurrence of limbal stem cell deficiency, following failed primary surgery for ocular burns, without adversely affecting donor eyes. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22265153     DOI: 10.1016/j.ajo.2011.09.016

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  38 in total

1.  [Long-term results of autologous transplantation of limbal epithelium cultivated ex vivo for limbal stem cell deficiency].

Authors:  S L Scholz; H Thomasen; K Hestermann; D Dekowski; K-P Steuhl; D Meller
Journal:  Ophthalmologe       Date:  2016-04       Impact factor: 1.059

2.  Systematic review and meta-analysis investigating autograft versus allograft cultivated limbal epithelial transplantation in limbal stem cell deficiency.

Authors:  Mohammad Amir Mishan; Mehdi Yaseri; Alireza Baradaran-Rafii; Mozhgan Rezaei Kanavi
Journal:  Int Ophthalmol       Date:  2019-03-02       Impact factor: 2.031

Review 3.  [Corneal cell therapy-an overview].

Authors:  M Fuest; G Hin-Fai Yam; G Swee-Lim Peh; P Walter; N Plange; J S Mehta
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

4.  Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cells.

Authors:  Eliska Javorkova; Peter Trosan; Alena Zajicova; Magdalena Krulova; Michaela Hajkova; Vladimir Holan
Journal:  Stem Cells Dev       Date:  2014-07-01       Impact factor: 3.272

Review 5.  Concise review: the coming of age of stem cell treatment for corneal surface damage.

Authors:  Charanya Ramachandran; Sayan Basu; Virender S Sangwan; Dorairajan Balasubramanian
Journal:  Stem Cells Transl Med       Date:  2014-09-09       Impact factor: 6.940

Review 6.  The application of human amniotic membrane in the surgical management of limbal stem cell deficiency.

Authors:  Qihua Le; Sophie X Deng
Journal:  Ocul Surf       Date:  2019-01-08       Impact factor: 5.033

7.  A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction.

Authors:  Vladimir Holan; Peter Trosan; Cestmir Cejka; Eliska Javorkova; Alena Zajicova; Barbora Hermankova; Milada Chudickova; Jitka Cejkova
Journal:  Stem Cells Transl Med       Date:  2015-07-16       Impact factor: 6.940

Review 8.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

Review 9.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033

10.  Mesenchymal stem cells, nanofiber scaffolds and ocular surface reconstruction.

Authors:  Vladimir Holan; Eliska Javorkova
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.